Location History:
- Berlin, DE (2008 - 2017)
- Berchtesgaden, DE (2017 - 2023)
Company Filing History:
12 out of 37 
5 out of 5 Years Active: 2008-2023
Title: Anke Klippel-Giese: Innovator in RNA Technology
Introduction
Anke Klippel-Giese is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of ribonucleic acid (RNA) technology, holding a total of 17 patents. Her work focuses on developing innovative RNA molecules that have the potential to impact various scientific and medical applications.
Latest Patents
Among her latest patents, Anke has developed interfering RNA molecules. These inventions relate to a ribonucleic acid comprising a double-stranded structure. The double-stranded structure consists of a first strand and a second strand. The first strand includes a stretch of contiguous nucleotides that is at least partially complementary to a target nucleic acid. The second strand contains a stretch of contiguous nucleotides that is at least partially identical to a target nucleic acid, with the double-stranded structure being blunt-ended.
Career Highlights
Anke Klippel-Giese has worked with notable companies in the biotechnology sector, including Silence Therapeutics GmbH and Silence Therapeutics Aktiengesellschaft. Her expertise in RNA technology has positioned her as a key player in the development of innovative therapeutic solutions.
Collaborations
Anke has collaborated with esteemed colleagues such as Jörg Kaufmann and Klaus Giese. These partnerships have further enhanced her research and development efforts in the field of RNA technology.
Conclusion
Anke Klippel-Giese is a trailblazer in RNA innovation, with a strong portfolio of patents and collaborations that highlight her contributions to science. Her work continues to pave the way for advancements in RNA-based therapies and technologies.